Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Ziracin evernimicin: Discontinued development

Schering-Plough Corp. (SGP), Madison, N.J.
Product:

Read the full 65 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE